January 6th 2023
Remember to keep the cart behind the horse while practicing medicine.
January 3rd 2023
Smoking and drinking (caffeine): Researchers analyzed caffeine intake and levels in smokers with schizophrenia and bipolar disorder.
December 30th 2022
Revisiting the CME articles featured in Psychiatric Times in 2022.
December 22nd 2022
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
December 17th 2022
From new legislation that would expand the US approach to mental health to drug abuse trends and treatment approaches for 2023, here are highlights from the week in Psychiatric Times.
Drug Abuse Trends and Treatment Approaches for 2023
What are the most pertinent drug trends to be aware of in 2023?
Assessing 2022: What’s the Prognosis in Psychiatry?
Survey Finds 1 in 7 Physicians Uses Alcohol or Drugs on the Job to Cope With Stress
"We must put mental health on par with physical health and make it a basic human right, an indicator of overall health, and an industry standard.”
The Road to Over-the-Counter Naloxone: FDA Releases Federal Register Notice
We may be one step closer to nonprescription naloxone.
Decriminalizing Mental Health: Partnering With Law Enforcement to Reduce Unwanted Outcomes
How can PMHNP consults with law enforcement reduce involuntary transfers and other unwanted outcomes?
Clinicians Embracing a Recovery Mindset: Mirroring Recovery to People You Serve
What is recovery?
Understanding the Long-Term Clinical Course of Comorbid SUD and ADHD
Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?
Expert Sheds Light on Opioid Overdose Crisis in Youth
Opioid use, addiction, and overdose in youth continue to increase. What can be done?
Must the Past Be Prologue?
A review of the Joint US-Canada Report on Substance Use and Harm.
Advocating for Medication for Opioid Use Disorder
The NCCHC and 166 national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.
My Patient Overdosed and Now I Feel Guilty…
First Responders and Mental Health: When Heroes Need Rescuing
As Suicide Prevention Month continues, we take a look at the mental health of a group constantly caring for others: first responders.
Contingency Management Is a Powerful Clinical Tool for Treating Substance Use Research Evidence and New Practice Guidelines for Use
Contingency management is an effective behavior change technique commonly used to treat substance use disorders.
Mood Shifts Have Opposite Impact on Alcohol Cravings in Men and Women
A new study finds mood shifts and alcohol-related cues affect men and women differently in terms of alcohol cravings.
A Matter of Life and Death: When Abortion Wars Should Not Be Fought
A psychiatrist reflects on how we can educate patients about avoiding alcohol misuse without getting caught up in polemics on politics.
The Role of Alcohol and Substances in Suicide
Suicide Prevention Week is September 4-10. Are you ready?
The Overdose Epidemic and the “Astounding” Life Expectancy Drop
New data shows a decrease in life expectancy in the United States. Here’s why.
From the Pages of Psychiatric Times: August 2022
The experts weighed in on a wide variety of psychiatric issues for the August 2022 issue of Psychiatric Times.
Understanding and Addressing Physician Substance Use and Misuse
“Doctors are great at hiding their addictions, especially from themselves... However, there are signs that something is wrong—be it addiction, depression, psychosis, or some other problem.”
A Whirlwind Tour of OUD Treatment Strategies
Opioid use disorder—how can we battle the epidemic of overdoses?
The Impact of Cannabis Use on Medication Nonadherence in Psychiatry
Cannabis use disorder and nonadherence: How can we best educate patients?
From the Pages of Psychiatric Times: July 2022
The experts weighed in on a wide variety of psychiatric issues for the July 2022 issue of Psychiatric Times.
Reducing Heavy Drinking Days: Positive Results From Trial for Medication Treating Alcohol Use Disorder
Positive results from the phase 3 trial of AD04 show a 79% reduction in heavy drinking.
Caregiving: Walking the Personal and Professional Tightrope
What happens when a clinician is faced with addiction in their own family?
Upcoming Release of Phase 3 Trial Results for Medication Treating Alcohol Use Disorder
New results are coming for AD04, a potential treatment for patients with alcohol use disorder.
Opioid Treatment “Mismatch” Threatens Vulnerable Communities
Treatment deserts are adding fuel to the fire of the opioid crisis.
Impact of Stigma for Patients With Dual Diagnosis
What is the clinician’s role in reversing stigma for better outcomes?
From the Pages of Psychiatric Times: June 2022
The experts weighed in on a wide variety of psychiatric issues for the June 2022 issue of Psychiatric Times.
Substance Misuse and Acquired Brain Injury
Understanding the intersection between substance misuse and acquired brain injury can assist clinicians in accurately diagnosing and treating these cooccurring conditions.
A Broken Healer: Navigating the Personal/Professional Tightrope of Caregiving
Clinicians are trained in how to help patients with substance use disorders—but what happens when the individual with a substance use disorder is a loved one?
2 Clarke Drive Cranbury, NJ 08512